| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aclarion, Inc. (ACON) has 2 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. ACON is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 17.0K | $55.8K | - | |
| CEO | 11 | $36.08 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Ness Brent | Chief Executive Officer | Buy | 10 | $6.20 | $62.00 | +1,000% | -59.4% | - | |
| Feb 16, 2023 | Thramann Jeffrey John | Executive Chairman | Buy | 1 | $1,000.00 | $1,000.00 | New | -0.4% | -85.1% | |
| Dec 29, 2022 | Lorbiecki John Paul | Chief Financial Officer | Buy | 22,404 | $0.45 | $10,000.00 | +546.5% | +32.7% | -63.6% | |
| Dec 29, 2022 | Ness Brent | Chief Executive Officer | Buy | 18,500 | $0.53 | $9,768.76 | +115.1% | +32.7% | -63.6% | |
| Apr 22, 2022 | Bond Ryan | Chief Strategy Officer | Buy | 20,000 | $2.80 | $56,000.00 | New | -69.1% | -72.8% | |
| Apr 21, 2022 | Wesemann William | Director | Buy | 11,000 | $4.35 | $47,850.00 | +26.4% | -69.1% | -72.8% | |
| Apr 21, 2022 | Ness Brent | Chief Executive Officer | Buy | 1,000 | $4.35 | $4,350.00 | New | -69.1% | -72.8% | |
| Apr 21, 2022 | Neal David K | Director | Buy | 34,400 | $4.35 | $149,640.00 | New | -69.1% | -72.8% |